Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s Why
by Kim Johansen · The Markets DailyCuraleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report)’s share price gapped down before the market opened on Friday. The stock had previously closed at $8.56, but opened at $8.28. Curaleaf shares last traded at $8.20, with a volume of 30,816 shares trading hands.
Analysts Set New Price Targets
CURLF has been the topic of a number of research reports. UBS Group set a $6.00 price objective on Curaleaf in a report on Monday, October 5th. Zacks Research lowered Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Finally, Citigroup reiterated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $6.00.
Read Our Latest Research Report on CURLF
Curaleaf Price Performance
The company has a quick ratio of 0.73, a current ratio of 1.52 and a debt-to-equity ratio of 1.06. The stock’s 50 day moving average price is $9.89 and its two-hundred day moving average price is $8.69. The stock has a market cap of $1.88 billion, a price-to-earnings ratio of -61.79 and a beta of 1.55.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. The company had revenue of $340.10 million during the quarter, compared to the consensus estimate of $332.00 million. Equities research analysts forecast that Curaleaf Holdings, Inc. will post 0.01 EPS for the current fiscal year.
About Curaleaf
Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.
Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.